J. Orbe, J. Barrenetxe, and J. Rodriguez, Matrix Metalloproteinase-10 Effectively Reduces Infarct Size in Experimental Stroke by Enhancing Fibrinolysis via a

B. Roussel, C. Mysiorek, and A. Rouhiainen, HMGB-1 promotes fibrinolysis and reduces neurotoxicity mediated by tissue plasminogen activator, Journal of Cell Science, vol.124, issue.12, pp.2070-2076, 2011.
DOI : 10.1242/jcs.084392
URL : https://hal.archives-ouvertes.fr/inserm-01296803

G. Koehl, A. Gaumann, and E. Geissler, Intravital microscopy of tumor angiogenesis and regression in the dorsal skin fold chamber: mechanistic insights and preclinical testing of therapeutic strategies, Clinical & Experimental Metastasis, vol.173, issue.Suppl 1, pp.329-373, 2009.
DOI : 10.1007/s10585-008-9234-7

Y. Harder, M. Amon, and D. Erni, Evolution of ischemic tissue injury in a random pattern flap: A new mouse model using intravital microscopy, Journal of Surgical Research, vol.121, issue.2, pp.197-205, 2004.
DOI : 10.1016/j.jss.2004.03.026

D. Nolte, M. Menger, and K. Messmer, Microcirculatory Models of Ischaemia-Reperf usion in Skin and Striated Muscle, International Journal of Microcirculation, vol.15, issue.1, pp.9-16, 1995.
DOI : 10.1159/000179088

H. Lehr, M. Leunig, and M. Menger, Dorsal skinfold chamber technique for intravital microscopy in nude mice, Am J Pathol, vol.143, pp.1055-62, 1993.

A. Eckly, B. Hechler, and M. Freund, Mechanisms underlying FeCl3-induced arterial thrombosis, Journal of Thrombosis and Haemostasis, vol.102, issue.4, pp.779-89, 2011.
DOI : 10.1111/j.1538-7836.2011.04218.x

R. Broersma, L. Kutcher, and E. Heminger, The effect of thrombin inhibition in a rat arterial thrombosis model, Thrombosis Research, vol.64, issue.4, pp.405-417, 1991.
DOI : 10.1016/0049-3848(91)90341-S

M. Kuijpers, I. Munnix, and J. Cosemans, Differential Sensitivity to Thrombin Inhibition, Microcirculation, vol.15, issue.4, pp.269-82, 2008.
DOI : 10.1080/10739680701653517

X. Wang, Q. Cheng, and L. Xu, Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice, Journal of Thrombosis and Haemostasis, vol.70, issue.4, pp.695-702, 2005.
DOI : 10.1111/j.1538-7836.2005.01236.x

S. Day, J. Reeve, and B. Pedersen, Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall, Blood, vol.105, issue.1, pp.192-200, 2005.
DOI : 10.1182/blood-2004-06-2225

C. Grines, P. Serruys, O. Neill, and . Ww, Fibrinolytic Therapy: Is It A Treatment of the Past?, Circulation, vol.107, issue.20, pp.2538-2580, 2003.
DOI : 10.1161/01.CIR.0000075292.29458.BB

E. Kilic, D. Hermann, and K. Hossmann, Recombinant tissue-plasminogen activator-induced thrombolysis after cerebral thromboembolism in mice, Acta Neuropathologica, vol.99, issue.3, pp.219-241, 2000.
DOI : 10.1007/PL00007430

C. Orset, R. Macrez, and A. Young, Mouse Model of In Situ Thromboembolic Stroke and Reperfusion, Stroke, vol.38, issue.10, pp.2771-2779, 2007.
DOI : 10.1161/STROKEAHA.107.487520

I. Jang, H. Gold, and A. Ziskind, Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator

M. Mazighi, J. Serfaty, and J. Labreuche, Comparison of intravenous alteplase with a combined intravenous???endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study, The Lancet Neurology, vol.8, issue.9, pp.802-811, 2009.
DOI : 10.1016/S1474-4422(09)70182-6

K. Ouriel, Current Status of Thrombolysis for Peripheral Arterial Occlusive Disease, Annals of Vascular Surgery, vol.16, issue.6, pp.797-804, 2002.
DOI : 10.1007/s10016-001-0318-y

H. Kim, S. Preece, and J. Black, Safety of catheter-directed thrombolysis for deep venous thrombosis in cancer patients, Journal of Vascular Surgery, vol.47, issue.2, pp.388-94, 2008.
DOI : 10.1016/j.jvs.2007.10.033

M. Mewissen, G. Seabrook, and M. Meissner, Catheter-directed Thrombolysis for Lower Extremity Deep Venous Thrombosis: Report of a National Multicenter Registry, Radiology, vol.211, issue.1, pp.39-49, 1999.
DOI : 10.1148/radiology.211.1.r99ap4739

W. Kuo, M. Van-den-bosch, and L. Hofmann, Catheter-Directed Embolectomy, Fragmentation, and Thrombolysis for the Treatment of Massive Pulmonary Embolism After Failure of Systemic Thrombolysis, Chest, vol.134, issue.2, pp.250-254, 2008.
DOI : 10.1378/chest.07-2846

W. Kuo, M. Gould, and J. Louie, Catheter-directed Therapy for the Treatment of Massive Pulmonary Embolism: Systematic Review and Meta-analysis of Modern Techniques, Journal of Vascular and Interventional Radiology, vol.20, issue.11, pp.1431-1471, 2009.
DOI : 10.1016/j.jvir.2009.08.002

C. Korninger and C. D. , Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro, Thromb Haemost, vol.46, pp.561-566, 1981.

H. Lijnen, B. Van-hoef, and V. Beelen, Characterization of the Murine Plasma Fibrinolytic System, European Journal of Biochemistry, vol.4, issue.3, pp.863-71, 1994.
DOI : 10.1016/0268-9499(94)90025-6

B. Lapergue, J. Moreno, and B. Dang, Protective Effect of High-Density Lipoprotein-Based Therapy in a Model of Embolic Stroke, Stroke, vol.41, issue.7, pp.1536-1578, 2010.
DOI : 10.1161/STROKEAHA.110.581512

D. Atochin, J. Murciano, and Y. Gursoy-ozdemir, Mouse Model of Microembolic Stroke and Reperfusion, Stroke, vol.35, issue.9, pp.2177-82, 2004.
DOI : 10.1161/01.STR.0000137412.35700.0e

C. Dubois, L. Panicot-dubois, and G. Merrill-skoloff, Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo, Blood, vol.107, issue.10, pp.3902-3908, 2006.
DOI : 10.1182/blood-2005-09-3687

Y. Boulaftali, B. Ho-tin-noe, and A. Pena, Platelet Protease Nexin-1, a Serpin That Strongly Influences Fibrinolysis and ThrombolysisClinical Perspective, Circulation, vol.123, issue.12, pp.1326-1360, 2011.
DOI : 10.1161/CIRCULATIONAHA.110.000885

W. Fay, D. Eitzman, and A. Shapiro, Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanisms, Blood, vol.83, pp.351-357, 1994.

C. Francis and V. Marder, Rapid formation of large molecular weight alpha-polymers in cross-linked fibrin induced by high factor XIII concentrations. Role of platelet factor XIII., Journal of Clinical Investigation, vol.80, issue.5, pp.1459-65, 1987.
DOI : 10.1172/JCI113226

J. Mcdonagh, R. Mcdonagh, . Jr, and J. Delage, Factor XIII in human plasma and platelets, Journal of Clinical Investigation, vol.48, issue.5, pp.940-946, 1969.
DOI : 10.1172/JCI106053

S. Kunitada, G. Fitzgerald, and D. Fitzgerald, Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction, Blood, vol.79, pp.1420-1427, 1992.

O. Zaidat, J. Suarez, and J. Sunshine, Thrombolytic therapy of acute ischemic stroke: correlation of angiographic recanalization with clinical outcome, AJNR Am J Neuroradiol, vol.26, pp.880-884, 2005.

K. Lees, E. Bluhmki, V. Kummer, and R. , Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials, The Lancet, vol.375, issue.9727, pp.1695-703, 2010.
DOI : 10.1016/S0140-6736(10)60491-6

C. Westerhout, E. Bonnefoy, and R. Welsh, The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: A pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST, American Heart Journal, vol.161, issue.2, pp.283-90, 2011.
DOI : 10.1016/j.ahj.2010.10.033
URL : https://hal.archives-ouvertes.fr/hal-00698395

P. Steg, E. Bonnefoy, and S. Chabaud, Impact of Time to Treatment on Mortality After Prehospital Fibrinolysis or Primary Angioplasty: Data From the CAPTIM Randomized Clinical Trial, Circulation, vol.108, issue.23, pp.2851-2857, 2003.
DOI : 10.1161/01.CIR.0000103122.10021.F2